MX382357B - Métodos y composiciones para tratar infecciones fúngicas cutáneas. - Google Patents
Métodos y composiciones para tratar infecciones fúngicas cutáneas.Info
- Publication number
- MX382357B MX382357B MX2019002047A MX2019002047A MX382357B MX 382357 B MX382357 B MX 382357B MX 2019002047 A MX2019002047 A MX 2019002047A MX 2019002047 A MX2019002047 A MX 2019002047A MX 382357 B MX382357 B MX 382357B
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- compositions
- methods
- fungal infections
- treating skin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010017533 Fungal infection Diseases 0.000 title 1
- 208000031888 Mycoses Diseases 0.000 title 1
- 230000001166 anti-perspirative effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003213 antiperspirant Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000002274 desiccant Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 201000004647 tinea pedis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662380787P | 2016-08-29 | 2016-08-29 | |
| PCT/US2017/047971 WO2018044621A1 (en) | 2016-08-29 | 2017-08-22 | Methods and compositions for treating cutaneous fungal infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019002047A MX2019002047A (es) | 2019-10-04 |
| MX382357B true MX382357B (es) | 2025-03-13 |
Family
ID=59799468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019002047A MX382357B (es) | 2016-08-29 | 2017-08-22 | Métodos y composiciones para tratar infecciones fúngicas cutáneas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10251822B2 (enExample) |
| EP (1) | EP3503874A1 (enExample) |
| JP (1) | JP2019526631A (enExample) |
| CN (1) | CN109862882A (enExample) |
| AU (1) | AU2017320876B2 (enExample) |
| CA (1) | CA3034839A1 (enExample) |
| MX (1) | MX382357B (enExample) |
| WO (1) | WO2018044621A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10993890B2 (en) * | 2018-03-15 | 2021-05-04 | Pelli Skin Co., Llc | Antifungal solution and foot wipe |
| CN111450128A (zh) * | 2020-06-01 | 2020-07-28 | 王刚建 | 一种用于治疗脚气的药物 |
| KR102217617B1 (ko) * | 2020-08-14 | 2021-02-19 | 비엘엔에이치 주식회사 | 백선의 예방 또는 치료용 약학적 조성물 |
| WO2022149300A1 (ja) * | 2021-01-08 | 2022-07-14 | 学校法人日本大学 | 白癬菌のスクアレンエポキシダーゼ阻害薬に対する耐性を判定する方法及び検査キット |
| CN117940109A (zh) | 2021-09-17 | 2024-04-26 | 持田制药株式会社 | 腋臭防止用组合物 |
| JP2025524432A (ja) * | 2022-06-21 | 2025-07-30 | タロー・ファーマシューティカル・インダストリーズ・リミテッド | 局所用ナフチフィン組成物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1024501A (en) * | 1962-02-21 | 1966-03-30 | Hardman & Holden Ltd | Improvements relating to aerosol preparations |
| US4083954A (en) * | 1975-04-04 | 1978-04-11 | Kao Soap Co., Ltd. | Aerosol composition |
| JPS5824511A (ja) * | 1981-07-17 | 1983-02-14 | クラウス・リ−マン・アンド・カンパニ−・エイピ−エス | 制汗用キツトとそのアプリケ−タ |
| US4551330A (en) * | 1983-06-30 | 1985-11-05 | Helene Curtis Industries, Inc. | Skin and hair conditioner compositions and conditioning method |
| DK483587D0 (da) * | 1987-09-15 | 1987-09-15 | Riemann & Co Aps Claus | Antiperspirant praeparat |
| US5468473A (en) * | 1994-02-09 | 1995-11-21 | Innova Products, Inc. | Antiperspirant for hands and feet |
| US7201914B2 (en) * | 2002-05-17 | 2007-04-10 | Xantech Pharmaceuticals, Inc. | Combination antiperspirant and antimicrobial composition |
| JP2004351632A (ja) * | 2003-05-27 | 2004-12-16 | Meisei Sansho Kk | 薬液含浸シート |
| US20050238672A1 (en) * | 2004-04-27 | 2005-10-27 | Nimni Marcel E | Antifungal drug delivery |
| US20060003654A1 (en) * | 2004-06-30 | 2006-01-05 | Lostocco Michael R | Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers |
| KR20060009093A (ko) * | 2004-07-20 | 2006-01-31 | 송재신 | 염산 테르비나핀을 함유하는 분말 에어로졸 조성물 |
| AU2006298748B2 (en) * | 2005-09-29 | 2010-06-03 | Karo Healthcare AB | Antifungal composition |
| JP2007091643A (ja) * | 2005-09-29 | 2007-04-12 | Nippon Nohyaku Co Ltd | 医療用抗白癬菌剤 |
| CN101808639B (zh) * | 2007-09-05 | 2012-12-05 | 宝丽制药股份有限公司 | 抗真菌医药组合物 |
| US20100056430A1 (en) * | 2008-08-27 | 2010-03-04 | Arnold Lester | Treatment and Method for Eliminating or Reducing Foot Odor |
| WO2010086726A1 (en) * | 2009-01-30 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compositions for nail and skin treatment |
| WO2010086727A1 (en) * | 2009-01-30 | 2010-08-05 | Galderma Pharma Sa | Stable compositions for nail onychomycosis treatment |
| US20120061267A1 (en) * | 2010-09-14 | 2012-03-15 | Sally Villalobos | MediTowel Anti-Fungal Wipe |
| EP2961385A4 (en) * | 2013-02-28 | 2016-07-27 | Prec Dermatology Inc | TOPICAL FORMULATIONS OF CORTICOSTEROIDS WITH INCREASED BIOAVAILABILITY |
| EP3388112A1 (en) * | 2013-10-09 | 2018-10-17 | Riemann Trading ApS | Improved antiperspirant composition |
| JP6975516B2 (ja) * | 2014-06-30 | 2021-12-01 | ロート製薬株式会社 | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 |
| RU2567036C1 (ru) * | 2014-10-28 | 2015-10-27 | Государственное бюджетное учреждение Республики Башкортостан "Научно-исследовательский технологический институт гербицидов и регуляторов роста растений с опытно-экспериментальным производством Академии наук Республики Башкортостан" | Средство ухода за кожей, обладающее антифунгальными свойствами (варианты) |
-
2017
- 2017-08-22 EP EP17762273.5A patent/EP3503874A1/en active Pending
- 2017-08-22 MX MX2019002047A patent/MX382357B/es unknown
- 2017-08-22 AU AU2017320876A patent/AU2017320876B2/en active Active
- 2017-08-22 CA CA3034839A patent/CA3034839A1/en not_active Abandoned
- 2017-08-22 US US15/683,416 patent/US10251822B2/en active Active
- 2017-08-22 WO PCT/US2017/047971 patent/WO2018044621A1/en not_active Ceased
- 2017-08-22 JP JP2019531863A patent/JP2019526631A/ja active Pending
- 2017-08-22 CN CN201780066597.1A patent/CN109862882A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018044621A1 (en) | 2018-03-08 |
| JP2019526631A (ja) | 2019-09-19 |
| CA3034839A1 (en) | 2018-03-08 |
| AU2017320876A1 (en) | 2019-03-07 |
| US10251822B2 (en) | 2019-04-09 |
| CN109862882A (zh) | 2019-06-07 |
| US20180055745A1 (en) | 2018-03-01 |
| MX2019002047A (es) | 2019-10-04 |
| EP3503874A1 (en) | 2019-07-03 |
| AU2017320876B2 (en) | 2022-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX382357B (es) | Métodos y composiciones para tratar infecciones fúngicas cutáneas. | |
| PH12018502634A1 (en) | Topical compositions of apremilast | |
| EA201892075A1 (ru) | Комбинации ингибиторов lsd1 для применения для лечения солидных опухолей | |
| PH12020551427A1 (en) | Epinephrine spray formulations | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| EA201791516A1 (ru) | Способы комбинированного лечения злокачественных опухолей | |
| MX2017010544A (es) | Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo. | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| JO3735B1 (ar) | مركبات ألكين بها استبدال رباعي واستخداماتها | |
| EA201992607A1 (ru) | Твердые формы берберина урсодезоксихолата, их композиции и способы | |
| BR112017009552A8 (pt) | Métodos para alvejar o controle transcricional em regiões de super-realçador | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| EA201591925A1 (ru) | Терапевтические композиции и их применение | |
| EA202091112A1 (ru) | Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение | |
| MX365366B (es) | Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné. | |
| MX2016015437A (es) | Combinacion que comprende un glucocorticoide y edo-s101. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| SA519410324B1 (ar) | صياغات رش إيبينيفرين | |
| JOP20200242A1 (ar) | مركبات البلاديينوليد واستخداماتها | |
| EA201691570A1 (ru) | Фармацевтическая композиция, включающая диамино-гетероциклическое карбоксамидное соединение в качестве активного ингредиента | |
| EA202190308A1 (ru) | Применение пролекарств рилузола для лечения болезни альцгеймера | |
| EA201991688A1 (ru) | Фармацевтические комбинации для лечения рака | |
| BR112019004791A2 (pt) | tratamento de esclerose múltipla com chs-131 | |
| MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
| BR112015018798A2 (pt) | composição antifúngica tópica para tratar onocomicose |